showed that in fungal infections in patients with end-stage liver disease, patients with invasive fungal infection (41.67% of the patients had Aspergillus infection)had higher serum IL-17 levels compared with patients without invasive fungal infection (Hassan et al., 2014). This evidence concerns the gene IL17A and fungal infectious disease.